These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B. Hui AY; Liew CT; Go MY; Chim AM; Chan HL; Leung NW; Sung JJ Liver Int; 2004 Dec; 24(6):611-8. PubMed ID: 15566512 [TBL] [Abstract][Full Text] [Related]
3. Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C. Lazzarini AL; Levine RA; Ploutz-Snyder RJ; Sanderson SO Liver Int; 2005 Dec; 25(6):1142-9. PubMed ID: 16343064 [TBL] [Abstract][Full Text] [Related]
4. Sampling variability of liver fibrosis in chronic hepatitis C. Bedossa P; Dargère D; Paradis V Hepatology; 2003 Dec; 38(6):1449-57. PubMed ID: 14647056 [TBL] [Abstract][Full Text] [Related]
5. Simplified method of hepatic fibrosis quantification: design of a new morphometric analysis application. Friedenberg MA; Miller L; Chung CY; Fleszler F; Banson FL; Thomas R; Swartz KP; Friedenberg FK Liver Int; 2005 Dec; 25(6):1156-61. PubMed ID: 16343066 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method. Maduli E; Andorno S; Rigamonti C; Capelli F; Morelli S; Colombi S; Nicosia G; Boldorini R; Abate M; Sartori M Ann Ital Med Int; 2002; 17(4):242-7. PubMed ID: 12532562 [TBL] [Abstract][Full Text] [Related]
7. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients. Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453 [TBL] [Abstract][Full Text] [Related]
8. Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability. Lee HS; Shun CT; Chiou LL; Chen CH; Huang GT; Sheu JC J Gastroenterol Hepatol; 2005 Jul; 20(7):1109-14. PubMed ID: 15955222 [TBL] [Abstract][Full Text] [Related]
9. [Role of liver biopsy in the assessment of hepatic fibrosis--its utility and limitations]. Jin SY Korean J Hepatol; 2007 Jun; 13(2):138-45. PubMed ID: 17585187 [TBL] [Abstract][Full Text] [Related]
10. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. Nahon P; Kettaneh A; Tengher-Barna I; Ziol M; de Lédinghen V; Douvin C; Marcellin P; Ganne-Carrié N; Trinchet JC; Beaugrand M J Hepatol; 2008 Dec; 49(6):1062-8. PubMed ID: 18930329 [TBL] [Abstract][Full Text] [Related]
11. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection. Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134 [TBL] [Abstract][Full Text] [Related]
12. Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors. Piscaglia F; Cucchetti A; Benlloch S; Vivarelli M; Berenguer J; Bolondi L; Pinna AD; Berenguer M Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1255-61. PubMed ID: 17099373 [TBL] [Abstract][Full Text] [Related]
13. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C. Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364 [TBL] [Abstract][Full Text] [Related]
14. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score? Tretheway D; Jain A; LaPoint R; Sharma R; Orloff M; Milot P; Bozorgzadeh A; Ryan C Liver Transpl; 2008 May; 14(5):695-700. PubMed ID: 18324621 [TBL] [Abstract][Full Text] [Related]
15. Assessment of hepatic steatosis: comparison of quantitative and semiquantitative methods in 108 liver biopsies. Turlin B; Ramm GA; Purdie DM; Lainé F; Perrin M; Deugnier Y; Macdonald GA Liver Int; 2009 Apr; 29(4):530-5. PubMed ID: 19018987 [TBL] [Abstract][Full Text] [Related]
16. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460 [TBL] [Abstract][Full Text] [Related]
18. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592 [TBL] [Abstract][Full Text] [Related]
19. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation. Rigamonti C; Donato MF; Fraquelli M; Agnelli F; Ronchi G; Casazza G; Rossi G; Colombo M Gut; 2008 Jun; 57(6):821-7. PubMed ID: 18218676 [TBL] [Abstract][Full Text] [Related]